News

August 22, 2018

Alpha Tau is in the last stages of raising an investment of several tens of millions of dollars.

Israeli oncology company Alpha Tau Medical Ltd. is in the last stages of raising an investment of several tens of millions of dollars, one person familiar with the matter to...

August 22, 2018

The new Sealed Source and Device (SSD) approval enables the commencement of clinical trials in leading hospitals across the U.S. with the company’s breakthrough cancer treatment, Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy).  

Boston, MA, August 21st 2018 --...

August 22, 2018

[..] Another company from Tel Aviv, Alpha Tau Medical, has partnered with Japanese biotechnology startup HekaBio to release radiation therapy equipment in Japan in 2021, at the earliest.

The product is designed to treat patients with breast, skin and other solid cancers...

July 15, 2018

Alpha Tau Medical focuses on research, development and commercialization of Alpha DaRT (Diffusing Alpha-Emitters Radiation Therapy) for the treatment of solid tumors. Alpha DaRT, initially developed at Tel Aviv University, was shown to be effective and safe for treatin...

May 22, 2018

מאפליקציה של מציאות מדומה שמפחיתה כאב ועד מכשיר כף יד שמציג פתרון לגילוי מאוחר של הסרטן. 4 חברות הציגו בכנס בינלאומי של מדעי החיים מיזמים חדשים בתחום.

קרא עוד

May 22, 2018

Alpha Tau Medical achieved great results at the Biomed MIXiii startup competition. The Alpha Tau team presented its highly potent and conformal Alpha DaRT cancer treatment with success!

Read more

March 23, 2018

At the first Alpha Tau Medical Summit, international participants from leading cancer centers discussed the application of Alpha DaRT (Diffusing Alpha-Emitters Radiation Therapy) to various cancer types.

The Biomed Company Alpha Tau Medical, which developed a highly eff...

Please reload

Categories
Please reload